AAAAAA

   
Results: 1-11 |
Results: 11
Analysis of risk factors for the development of GVHD after T cell-depletedallogeneic BMT: Effect of HLA disparity, ABO incompatibility, and method of T-cell depletion
Authors: Keever-Taylor, CA Bredeson, C Loberiza, FR Casper, JT Lawton, C Rizzo, D Burns, WH Margolis, DA Vesole, DH Horowitz, M Zhang, MJ Juckett, M Drobyski, WR
Citation: Ca. Keever-taylor et al., Analysis of risk factors for the development of GVHD after T cell-depletedallogeneic BMT: Effect of HLA disparity, ABO incompatibility, and method of T-cell depletion, BIOL BLOOD, 7(11), 2001, pp. 620-630
Protection from lethal murine graft-versus-host disease without compromiseof alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene
Authors: Drobyski, WR Morse, HC Burns, WH Casper, JT Sandford, G
Citation: Wr. Drobyski et al., Protection from lethal murine graft-versus-host disease without compromiseof alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene, BLOOD, 97(8), 2001, pp. 2506-2513
Evolving strategies to address adverse transplant outcomes associated withT cell depletion
Authors: Drobyski, WR
Citation: Wr. Drobyski, Evolving strategies to address adverse transplant outcomes associated withT cell depletion, J HEMATH ST, 9(3), 2000, pp. 327-337
Quantitative evaluation of post-bone marrow transplant engraftment status using fluorescent-labeled variable number of tandem repeats
Authors: Luhm, RA Bellissimo, DB Uzgiris, AJ Drobyski, WR Hessner, MJ
Citation: Ra. Luhm et al., Quantitative evaluation of post-bone marrow transplant engraftment status using fluorescent-labeled variable number of tandem repeats, MOL DIAGN, 5(2), 2000, pp. 129-138
Adoptively transferred gamma delta T cells indirectly regulate murine graft-versus-host reactivity following donor leukocyte infusion therapy in mice
Authors: Drobyski, WR Vodanovic-Jankovic, S Klein, J
Citation: Wr. Drobyski et al., Adoptively transferred gamma delta T cells indirectly regulate murine graft-versus-host reactivity following donor leukocyte infusion therapy in mice, J IMMUNOL, 165(3), 2000, pp. 1634-1640
T-cell depletion plus salvage immunotherapy with donor leukocyte infusionsas a strategy to treat chronic-phase chronic myelogenous leukemia patientsundergoing HLA-identical sibling marrow transplantation (vol 94, pg 434, 1999)
Authors: Drobyski, WR Hessner, MJ Klein, JP Kabler-Babbitt, C Vesole, DH Margolis, DA Keever-Taylor, CA
Citation: Wr. Drobyski et al., T-cell depletion plus salvage immunotherapy with donor leukocyte infusionsas a strategy to treat chronic-phase chronic myelogenous leukemia patientsundergoing HLA-identical sibling marrow transplantation (vol 94, pg 434, 1999), BLOOD, 95(4), 2000, pp. 1137-1137
Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions
Authors: Porter, DL Collins, RH Hardy, C Kernan, NA Drobyski, WR Giralt, S Flowers, MED Casper, J Leahey, A Parker, P Mick, R Bate-Boyle, B King, R Antin, JH
Citation: Dl. Porter et al., Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions, BLOOD, 95(4), 2000, pp. 1214-1221
T-cell depletion of bone marrow transplants for leukemia from donors otherthan HLA-identical siblings: advantage of T-cell antibodies with narrow specificities
Authors: Champlin, RE Passweg, JR Zhang, MJ Rowlings, PA Pelz, CJ Atkinson, KA Barrett, AJ Cahn, JY Drobyski, WR Gale, RP Goldman, JM Gratwohl, A Gordon-Smith, EC Henslee-Downey, PJ Herzig, RH Klein, JP Marmont, AM O'Reilly, RJ Ringden, O Slavin, S Sobocinski, KA Speck, B Weiner, RS Horowitz, MM
Citation: Re. Champlin et al., T-cell depletion of bone marrow transplants for leukemia from donors otherthan HLA-identical siblings: advantage of T-cell antibodies with narrow specificities, BLOOD, 95(12), 2000, pp. 3996-4003
Herpes simplex thymidine kinase (HStk) transgenic donor lymphocytes
Authors: Burt, RK Drobyski, WR Traynor, AE Link, CJ
Citation: Rk. Burt et al., Herpes simplex thymidine kinase (HStk) transgenic donor lymphocytes, BONE MAR TR, 24(10), 1999, pp. 1043-1051
T-cell depletion plus salvage immunotherapy with donor leukocyte infusionsas a strategy to treat chronic-phase chronic myelogenous leukemia patientsundergoing HLA-identical sibling marrow transplantation
Authors: Drobyski, WR Hessner, MJ Klein, JP Kabler-Babbitt, C Vesole, DH Keever-Taylor, CA
Citation: Wr. Drobyski et al., T-cell depletion plus salvage immunotherapy with donor leukocyte infusionsas a strategy to treat chronic-phase chronic myelogenous leukemia patientsundergoing HLA-identical sibling marrow transplantation, BLOOD, 94(2), 1999, pp. 434-441
The use of the polymerase chain reaction to predict for subsequent relapsein unrelated marrow transplantation for chronic myelogenous leukemia
Authors: Drobyski, WR Hessner, MJ
Citation: Wr. Drobyski et Mj. Hessner, The use of the polymerase chain reaction to predict for subsequent relapsein unrelated marrow transplantation for chronic myelogenous leukemia, LEUK LYMPH, 31(3-4), 1998, pp. 317-323
Risultati: 1-11 |